Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,977 public trials 3,763 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

NCT06011954

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Site KR82001 Goyang-si, Gyeonggi-do, South Korea
  • Site KR82012 Suwon, Gyeonggi-do, South Korea
  • Site KR82008 Suwon, Gyeonggi-do, South Korea
  • Site KR82007 Jeollanam-do, South Korea
View all 18 locations
View Trial Details
Recruiting

Investigations of Reproductive Cancers in Women

NCT06527157

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +9 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Advent Health Orlando Orlando, Florida, United States
  • Ob-Gyne Associates of Lake Forest, Ltd Lake Forest, Illinois, United States
  • Indiana University, Eskenazi Health Indianapolis, Indiana, United States
View all 16 locations
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)

NCT07710157

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
Locations
  • Division of Nephrology, Department of Internal Medicine, Medical University of Graz Graz, Austria
  • Department of Internal Medicine IV, Nephrology and Hypertension Innsbruck, Austria
  • 6. Medizinische Abteilung mit Nephrologie & Dialyse, Klinik Ottakring Vienna, Austria
  • Laboratory of Immunology, Nice University Hospital (CHU de Nice), Côte d'Azur University Nice, France
View Trial Details
Recruiting

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT07665515

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital Cambridge, United Kingdom
  • The University of Edinburgh - Western General Hospital - Edinburgh Cancer Research Centre Edinburgh, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • St. James's University Hospital Leeds, United Kingdom
View Trial Details
Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details

Related conditions